Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

How many patents does a biopharmaceutical company need?

Nature Biotechnology volume 26, pages 763–766 (2008)Cite this article

Young biotech companies may not need extensive patent portfolios to survive or grow.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Hubbard, T. & Love, J. PLoS Biol. 2, 147–150 (2004).

    Article  Google Scholar 

  2. Nathan, C. Nat. Med. 13, 304–308 (2007).

    Article  CAS  Google Scholar 

  3. Aggarwal, S., Gupta, V. & Bagchi-Sen, S. Nat. Biotechnol. 24, 643–651 (2006).

    Article  CAS  Google Scholar 

  4. Pisano, G.P. Science Business: The Promise, the Reality and the Future of Biotech (Harvard Business School Press, Boston, MA, 2006).

    Google Scholar 

  5. Simon, F. & Kotler, P. Building Global Biobrands. Taking Biotechnology to Market (Free Press, New York, 2003).

    Google Scholar 

Download references

Acknowledgements

During the course of this work, D.K.P. was a student intern from Vellore Institute of Technology, Vellore. He is currently with Tata Consultancy Services. R.M. is now with Avesthagen Ltd. We thank N. Yathindra for bringing Science Business by G.P. Pisano to our attention. We also thank Sunitha Yadav, Nanda Pandey and Sujith Raj Kothapeta for their work on the companies formed before 1992. Financial support from the Wadhwani Foundation is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Deepak Kumar Parida, Ritu Mehdiratta and Gayatri Saberwal are at the Institute of Bioinformatics and Applied Biotechnology, NEN-Wadhwani Centre of Excellence in Entrepreneurship Education, G-05 Tech Park Mall, ITPB, Whitefield Road, Bangalore 560 066, India. gayatri@ibab.ac.in ,

    Deepak Kumar Parida, Ritu Mehdiratta & Gayatri Saberwal

Authors
  1. Deepak Kumar Parida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ritu Mehdiratta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gayatri Saberwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Although none of the authors was directly supported by industry, the Institute of Bioinformatics and Applied Biotechnology (IBAB) has received support from, and has collaborations with, biotech and pharma companies.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parida, D., Mehdiratta, R. & Saberwal, G. How many patents does a biopharmaceutical company need?. Nat Biotechnol 26, 763–766 (2008). https://doi.org/10.1038/nbt0708-763

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0708-763

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing